Hyaluronidase (Human Recombinant): Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Hyaluronidase (Human Recombinant). Educational only — not medical advice.
Labeled uses
1.1 Subcutaneous Fluid Administration HYLENEX recombinant is indicated as an adjuvant in subcutaneous fluid administration for achieving hydration. 1.2 Dispersion and Absorption of Injected Drugs HYLENEX recombinant is indicated as an adjuvant to increase the dispersion and absorption of other injected drugs. 1.3 Subcutaneous Urography HYLENEX recombinant is indicated as an adjunct in subcutaneous urography for improving resorption of radiopaque agents.
Source: FDA labeling via NIH DailyMed (set c3f1db01…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.